DIAGNOSTIC TECHNOLOGIES
- Altering Bone Density by Modulating SOST Expression via Tissue-specific Enhancers
- Aptamer for the Histidine Tag and an Improved Method for the Generation of High Affinity Aptamers
- Assays Based on the Role of Dystroglycan and Alpha-Dystroglycan Proteolysis in Tumor Cell Growth
- Biomarker for Cell Senescence
- Biohazard Control Station
- Breast Cancer Signature Predictive of Clinical Outcome

- Catalyst Exchanges Deuterium or Tritium into Organic and Organometallic Compounds
- Cells-On-A-Chip: Apparatus for Real-Time and Label-Free Molecular Imaging of Live Cells and Bacteria

- Color and Shape Changing Polymeric Ribbons and Sheets
- Colorimetric and Fluorescent Sensors for Rapid and Direct Detection of Influenza, E. coli, and Other Analytes
- Comprehensive Prognostic Markers and Therapeutic Targets for Drug-Resistant Breast Cancers
- Co-registration of PET and Transrectal Ultrasound (TRUS) Images for Improved Prostate Imaging and Biopsy

- Diagnostic MRI Skin Map Database

- Diagnostic Test to Personalize Therapy Using Platinum-based Anticancer Drugs

- Early Detection of Metastatic Cancer Progenitor Cells

- Early Identification of Vulnerable Atherosclerotic Plaques Using In Vivo MIR Spectroscopy and Imaging
- Fast Scintillation Detectors Using Direct-Gap Semiconductors
- Full Karyotype Analysis for Increasing Pregnancy Rates per IVF Cycle
- Genes Encoding Telomere-Associated Proteins
- Heart and Torso Phantom Model of Cardiac and Respiratory Motion for Nuclear Imaging

- High Selectivity Peptides for Cancer Therapy, Screening for Cancer Therapies, and Therapy Sensitization

- Low-resistivity Photon-transparent Window Attached to Photo-sensitive Silicon Detector
- Metabolic Markers for Noninvasive Diagnosis of Crohn’s Disease

- Mobile Ex-Situ High Resolution NMR and MRI
- Noninvasive Detection of Preclinical Cardiovascular Disease
- Non-Transgenic Cell Lines for Identifying Target Premalignant Genes

- Portable, High Resolution NMR/MRI in Inhomogeneous Fields
- Predictive Markers and Therapeutic Targets for Drug Resistant Ovarian Cancer
- Prognostic for Invasive and Metastatic Cancers
- Protease-based Cancer Screening Using Nanoliter Samples
- Quantum Dot Based Cell Motility, Invasion, and Metastasis Assays
- Rac1b: A Highly Selective Marker and Target for Cancer
- Rotenone Analogs: High Extraction and Retention Perfusion Tracers for PET and SPECT Imaging
- Simple Colorimetric Biological Barcode Amplification Assay
- Single Step, Real-Time Protein Kinase Detection For Biological Screening
- Sub-100 ps Time Digitizer for High Throughput PET
- SQUIDS
- Tritium Labeled, High Specific Activity Compounds
GENOMIC
- A Cell Injection System Using Carbon Nanotubes

- Antibodies for Monitoring and Phosphorylation Sites for Inhibiting DNA Double-Strand Break Repair
- Automated Protein Crystal Mounting and Alignment
- Biological Production of Polymer Monomers

- Comprehensive Prognostic Markers and Therapeutic Targets for Drug-Resistant Breast Cancers
- Electrospray Emitters for Integrating Mass Spectrometry with Microfluidic Devices
- Genomic and Proteomic Software
- Genomic Screening Suitable for Routine Clinic and At Home Use

- High Selectivity Peptides for Cancer Therapy, Screening for Cancer Therapies, and Therapy Sensitization

- Improved Phylogenic Microarray Design and Analysis Tools

- Improved Procedure for Refolding Insoluble Proteins
- Mass Spectrometer for High Molecular Weight Ions and Charged Particles
- Methods and Proteins for Developing New Classes of Antibiotics

- Molecular Ruler for Label-free Measurement of Protein-DNA Interactions
- Monolithic Polymers Revolutionize Microfluidic Devices
- New High Performance Hybrid Magnets for High-throughput DNA and Molecule Separation
- Non-Transgenic Cell Lines for Identifying Target Premalignant Genes

- Optimum Protein Solubility Screen
- PhyloChip: DNA Microarray for Rapid Profiling of Microbial Populations

- Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders

- Predictive Markers and Therapeutic Targets for Drug Resistant Ovarian Cancer
- Prognostic for Invasive and Metastatic Cancers
- Rac1b: A Highly Selective Marker and Target for Cancer
- Recovery of cDNAs from Plasmid Libraries
- SATB1: A Fundamental Prognostic Marker and Therapeutic Target for Metastatic Breast Cancer

- Simple Colorimetric Biological Barcode Amplification Assay
- Single Step, Real-Time Protein Kinase Detection For Biological Screening
- Spatially Controlled Surface Modification of Plastic Microfluidic Devices
- TACE Inhibition for Treating High-Risk Cancers and Enhancing Current EGFR Therapies
MOUSE MODELS
- PR-A Transgenic Mice Allow Study of Female Reproductive Endocrinology
- Sterile Transgenic Mice Model: Male Infertility
- Transgenic Mice: Atherosclerosis Portfolio
- Transgenic Mice: Breast Cancer and Leukemia
RESEARCH TOOLS
- A Cell Injection System Using Carbon Nanotubes

- Altering Bone Density by Modulating SOST Expression via Tissue-specific Enhancers
- Apparatus and Instrumentation for Single Molecule Spectroscopy
- Automated Desealer for Microtiter Plates

- Automated Electron Microscopy Film Scanner
- Electrospray Emitters for Integrating Mass Spectrometry with Microfluidic Devices

- Growth of Large Patterned Arrays Of Neurons on CCD Chips Using Plasma Deposition Methods
- Improved Procedure for Refolding Insoluble Proteins
- Long-term Growth of Finite Life Span Normal Human Epithelial Cells
- Membrane-Derivatized Colloids for the Detection and Analysis of Cell Membrane Binding Interactions
- Methods and Proteins for Developing New Classes of Antibiotics

- Molecular Ruler for Label-free Measurement of Protein-DNA Interactions
- New High Performance Hybrid Magnets for High-throughput DNA and Molecule Separation
- Non-Transgenic Cell Lines for Identifying Target Premalignant Genes
- Optimum Protein Solubility Screen
- PhyloChip: DNA Microarray for Rapid Profiling of Microbial Populations

- Predictive Methodology and Tools for Nanotoxicology
- Rac1b: A Highly Selective Marker and Target for Cancer
-
Rapid, Efficient Extraction of Biomolecules from Electrophoretic Gels

- Single Step, Real-Time Protein Kinase Detection For Biological Screening
- Spatially Controlled Surface Modification of Plastic Microfluidic Devices
- Transmission Electron Microscope Phase-contrast Enhancement
THERAPEUTIC
- Acid-Degradeable and Bioerodible Materials

- Altering Bone Density by Modulating SOST Expression via Tissue-specific Enhancers
- An Apolipoprotein that Strongly Modulates Plasma Triglyceride Levels
- Antibodies for Monitoring and Phosphorylation Sites for Inhibiting DNA Double-Strand Break Repair
- ANXA9: A Therapeutic Target and Predictive Marker for Early Detection of Aggressive Breast Cancer

- Apolipoprotein A-1 Variants for Reducing Cardiovascular-Related Risks
- Berkeley Ergonomic Arm
- Biomimetic Agents for Replacement of NAD+/NADH in Enzymatic Reactions
- Bone Replacement Materials
- Breast Cancer Therapy and Potential Method for Enhancing Radiation Sensitivity via Inhibition of ß1 Integrin
- Compact Systems for Effective and Precise Brachytherapy
- Comprehensive Prognostic Markers and Therapeutic Targets for Drug-Resistant Breast Cancers
- Diagnostic MRI Skin Map Database

- High Selectivity Peptides for Cancer Therapy, Screening for Cancer Therapies, and Therapy Sensitization

- Identifying Biomarkers of Physiological Responses of Cancer Cells

- Identifying Improved Aminoglycoside Antibiotics

- Membrane Microarrays for Cell Manipulation
- Methods and Proteins for Developing New Classes of Antibiotics

- Microgels with Acid-Degradable Cross-Linkers for Vaccine and Cytoplasmic Drug Delivery
- Microgels with Acid-Degradable Polymer Backbones for Delivering Bioactive Materials

- Mineralization of Biocompatible Scaffolds
- Nano-onion Therapy for Cancer Tumors
- Novel NMR-based Xenon Biosensor
- Polymerized Nanoparticle Therapeutics
- Predictive Markers and Therapeutic Targets for Drug Resistant Ovarian Cancer
- Rac1b: A Highly Selective Diagnostic Marker and Therapeutic Target for Cancer
- SATB1: A Fundamental Prognostic Marker and Therapeutic Target for Metastatic Breast Cancer

- Synthetic Nano-Low Density Lipoprotein As a Targeted Drug Delivery Vehicle
- Synthetic Peptide that Causes Bundling of F-Actin in Vitro and in Situ
- TACE Inhibition for Treating High-Risk Cancers and Enhancing Current EGFR Therapies
- Tendon Repair Factor
- Tissue-Engineering Phage Therapy for Neural Regeneration

